Research Topics
Genomes and Genes | B W ScheithauerSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
The pituitary in Turner syndromeB W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Endocr Pathol 16:195-200. 2005....
Pituitary blastoma: a unique embryonal tumorBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street, SW Rochester, MN 55905, USA
Pituitary 15:365-73. 2012..Variable MGMT reactivity suggests an incomplete response to temozolomide therapy. Literature regarding similar morphologically complex, infantile, Cushing disease-associated lesions is briefly reviewed...
Pituitary blastomaBernd W Scheithauer
Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA
Acta Neuropathol 116:657-66. 2008....
Pituitary adenoma with tumoral granulomatous reactionBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Endocr Pathol 18:86-90. 2007..Histochemical and polymerase chain reaction (PCR) studies revealed neither fungi nor tubercle bacilli. We suggest that tumoral production of an as yet uncharacterized antigen may have induced the granulomatous inflammatory reaction...
Synovial sarcoma of nerveBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Hum Pathol 42:568-77. 2011..Definitive recommendations regarding surgery and adjuvant therapies await additional reports and long-term follow-up. The literature is reviewed and a meta-analysis is performed with respect to clinicopathologic features versus outcome...
Pituitary carcinoma: a clinicopathological reviewBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55901, USA
Neurosurgery 56:1066-74; discussion 1066-74. 2005..Recent studies have only begun to shed light on the probable mechanisms of tumor initiation and progression. A review of the clinicopathological and molecular genetic characteristics of pituitary carcinomas is presented...
Immunoexpression of androgen receptor in the nontumorous pituitary and in adenomasBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Endocr Pathol 19:27-33. 2008..No staining of thyroid-stimulating hormone adenomas was noted. The physiologic significance of our findings remains to be explored. The literature regarding AR expression in animal and human pituitaries is reviewed...
Glomus tumor and glomangioma of the nerve. Report of two casesBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurosurg 108:348-56. 2008..An uneventful postoperative recovery was noted in both patients. Glomus tumors and glomangiomas can involve major nerves on rare occasions. They seem to follow a favorable clinical course, and conservative resection can be of benefit...
Ganglioglioma of the neurohypophysisB W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Endocr Pathol 19:112-6. 2008..The morphologic and immunohistochemical features of the tumor are presented, cytogenetic considerations are discussed, and literature regarding neuronal lesions of the pituitary gland is reviewed...
The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathologyBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Brain Pathol 18:307-16. 2008..These issues and others are the substance of this and an upcoming companion article...
Ependymoma of the sella turcica: a variant of pituicytomaBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Hum Pathol 40:435-40. 2009..The literature is reviewed and concepts of histogenesis are explored, particularly an origin in "ependymal pituicytes." The concept that sellar ependymoma is pituicyte-derived is explored...
Rosette-forming glioneuronal tumor: report of a chiasmal-optic nerve example in neurofibromatosis type 1: special pathology reportBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
Neurosurgery 64:E771-2; discussion E772. 2009..Its occurrence in the posterior fossa and association with the fourth ventricle is stereotypical and a feature of all reported cases...
Synovial sarcoma of the sellar regionBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St, SW, Rochester, MN 55905, USA
Neuro Oncol 9:454-9. 2007..Subtotal resection and radiosurgery proved to be efficacious. The spectrum of primary sellar region sarcomas is summarized...
Pathobiology of pituitary adenomas and carcinomasBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Neurosurgery 59:341-53; discussion 341-53. 2006....
Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 casesBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 33:325-38. 2009..Malignant cranial nerve sheath tumors are rare and are associated with the same poor prognosis as those of spinal nerves at other sites...
Development of the WHO classification of tumors of the central nervous system: a historical perspectiveBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Brain Pathol 19:551-64. 2009..Four versions of its Classification of Tumours of the Central Nervous System have been published. The present work chronicles their progress, placing emphasis on the historical context of the earliest effort...
Anaplastic astroblastoma-sarcoma in neurofibromatosis Type 1B W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Clin Neuropathol 29:289-96. 2010..The latter alterations, having been reported in astroblastoma, were noted in both tumor components, thus confirming the common origin of the glial and sarcomatous elements...
Diffuse ganglioneuromatosis and plexiform neurofibroma of the urinary bladder: report of a pediatric example and literature reviewBernd W Scheithauer
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Hum Pathol 39:1708-12. 2008..At present, there are no established criteria for the treatment of this rare lesion...
Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo exampleBernd W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Hum Pathol 40:270-8. 2009..The literature regarding thyrotropin carcinomas is reviewed. Based on the study of several biopsies during disease progression, we believe that the carcinoma originated de novo without an intermediary adenoma phase...
The pituitary in klinefelter syndromeB W Scheithauer
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Endocr Pathol 16:133-8. 2005..The testes are small, blood testosterone levels are low, and blood gonadotropin levels are elevated. Pituitary changes in patients with Klinefelter syndrome have not been evaluated in detail...
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic featuresChristine E Fuller
Department of Pathology, Washington University School of Medicine, St Louis, Missouri, USA
J Neuropathol Exp Neurol 62:1118-28. 2003..We conclude that 1) distinct genetic subsets are identifiable by FISH in morphologically ambiguous gliomas, and 2) both histological grading and molecular analysis yield prognostically useful information...
Pituitary carcinoma: an ultrastructural study of eleven casesB W Scheithauer
Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
Ultrastruct Pathol 25:227-42. 2001..Despite the diagnostic utility of electron microscopy in the assessment of these rare tumors, the distinction of pituitary carcinoma from pituitary adenoma cannot be firmly made on ultrastructural grounds alone...
Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?P C Burger
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Neuropathol Exp Neurol 60:1099-104. 2001..0004 with an exact test). We conclude that EGFR amplification is associated with a small cell phenotype in GBMs and that SCGBMs are an important component of "primary" GBMs...
Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic studyO Kurtkaya-Yapicier
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Ultrastruct Pathol 26:345-53. 2002..The lack of morphologic similarity between the 2 adenomas indicatesthat pituitary tumors in patients with Carney complex may not exhibit the same phenotype...
Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissuesV Tziortzioti
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA
Endocr Pathol 12:125-36. 2001....
Coexisting corticotroph and lactotroph adenomas: case report with reference to the relationship of corticotropin and prolactin excessA G Wynne
Division of Endocrinology, Mayo Clinic, Rochester, Minnesota
Neurosurgery 30:919-23. 1992..The mechanisms underlying simultaneous adrenocorticotropic hormone and prolactin excess are discussed...
Results of treatment of pituitary disease in multiple endocrine neoplasia, type IT O'BRIEN
Division of Endocrinology Metabolism and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Neurosurgery 39:273-8; discussion 278-9. 1996..The aim of the present study was to examine the clinical and pathological features of pituitary disease in patients with multiple endocrine neoplasia, Type I (MEN I) and to assess the prognosis...
PS6K amplification characterizes a small subset of anaplastic meningiomasD X Cai
Department of Pathology, Washington University School of Medicine, 660 S Euclid Ave, Box 8118, St Louis, MO 63110, USA
Am J Clin Pathol 115:213-8. 2001..Further studies are needed to map the 17q23 amplicon to determine whether additional genes in this region are amplified in high-grade meningiomas...
Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitariesL Jin
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Pathol 151:509-19. 1997....
Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumorsT A Gaffey
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Clin Neuropathol 24:56-63. 2005..When compared to long-term follow-up, neither this parameter nor ploidy correlated with tumor size or invasiveness. Lastly, long-term follow-up showed ploidy to be an unreliable predictor of tumor persistence or recurrence...
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancersR V Lloyd
Department of Laboratory Medicine and Pathology, Mayo Foundation and Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Pathol 154:313-23. 1999..We also review studies indicating the increasingly important roles of p27, other CDKIs, and cyclins in endocrine cell hyperplasia and tumor development...
Surgical outcome and predictive factors in adult patients with intractable epilepsy and focal cortical dysplasiaA M Siegel
Division of Epilepsy, Mayo Clinic, Rochester, MN 55905, USA
Acta Neurol Scand 113:65-71. 2006..02). CONCLUSION: Adult patients with FCD may be candidates for surgical treatment of intractable partial epilepsy. Most individuals have neocortical, extrahippocampal seizures and approximately 50% of patients are rendered seizure-free...
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade gliomaJ C Buckner
Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Cancer 92:420-33. 2001....
Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic studyFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 31:351-62. 2007....
Identification and consequences of galectin-3 expression in pituitary tumorsA Righi
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Mol Cell Endocrinol 326:8-14. 2010..Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors...
Expression of diagnostic neuronal markers and outcome in glioblastomaK Donev
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Neuropathol Appl Neurobiol 36:411-21. 2010..High-grade gliomas featuring giant cells, often demonstrate immunoreactivity for neuronal markers, a finding prognostically significant according to some studies. We investigated this event in glioblastomas (GBM)...
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformationD Zimmerman
Department of Pediatrics, Mayo Clinic, Rochester, Minnesota 55905
J Clin Endocrinol Metab 76:216-22. 1993..The peripheral plasma immunoreactive GHRH concentration remained unaffected by pharmacological and surgical interventions. We suspect that a congenital hypothalamic regulatory defect may be responsible for the GHRH excess in this case...
Myosin XVA expression in the pituitary and in other neuroendocrine tissues and tumorsR V Lloyd
Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Am J Pathol 159:1375-82. 2001..These data suggest that in neuroendocrine cells myosin XVA may have a role in secretory granule movement and/or secretion...
Sex- and age-related differences in ceramide dihexosides of primary human brain tumorsA J Yates
Department of Pathology, The Ohio State University, Columbus 43210, USA
Lipids 34:1-4. 1999....
Leptin and leptin receptor in anterior pituitary functionR V Lloyd
Department of Laboratory Medicine and Pathology, Mayo Foundation, Rochester, MN 55905, USA
Pituitary 4:33-47. 2001..These proteins are activated by tyrosine-phosphorylation in anterior pituitary cells. The various steps in pituitary leptin signal transduction remain to be elucidated...
Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomasK H Ruebel
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Endocr Pathol 12:281-9. 2001....
Tumefactive demyelination and glioblastoma: a rare collision lesionS F Roemer
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Clin Neuropathol 30:186-91. 2011..Termed "tumefactive demyelination" it often prompts a brain biopsy...
The spectrum of malignancy in craniopharyngiomaFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 31:1020-8. 2007..De novo malignancy in odontogenic tumors of the sella is even more unusual, but also has an ominous prognosis...
Infiltrative astrocytomas with granular cell features (granular cell astrocytomas): a study of histopathologic features, grading, and outcomeDaniel J Brat
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Am J Surg Pathol 26:750-7. 2002..6 months). Two patients died postoperatively, and one was alive at 51 months. Granular cell astrocytoma is an uncommon morphologic variant that appears to be rapidly progressive and usually fatal...
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and gradingC Giannini
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neuropathol Exp Neurol 60:248-62. 2001..Our study found few factors independently associated with cause specific-survival among morphological parameters. These findings are consistent with the present WHO stratification of oligodendrogliomas into low- and high-grade variants...
Extraventricular neurocytomas: pathologic features and clinical outcomeD J Brat
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Am J Surg Pathol 25:1252-60. 2001..Thus, the majority of EVNs are well differentiated and appear unlikely to recur after gross total resection. Subtotal resection, atypical histologic features, and high cell proliferation rates correlate with recurrence...
"Rhabdoid" meningioma: an aggressive variantA Perry
Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 22:1482-90. 1998..Report of four cases. Am J Surg Pathol 1998;22:231-8). They further suggest that rhabdoid meningiomas are highly aggressive tumors and that the rhabdoid phenotype represents a marker of malignant transformation in meningiomas...
Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patientsJ L Oblinger
Department of Pathology, The Ohio State University, Columbia, OH, USA
Neuropathol Appl Neurobiol 32:410-8. 2006..In summary, the data indicate that measuring glycosyltransferase mRNA levels by real-time PCR may be clinically useful for determining both diagnosis and prognosis in GBM patients...
Transformation of low grade glioma and correlation with outcome: an NCCTG database analysisK A Jaeckle
Mayo Clinic, Cannaday 2 E, Jacksonville, FL 32224, USA
J Neurooncol 104:253-9. 2011..From time of recurrence, OS was not significantly different for those with primary versus secondary GBM, and it may thus be reasonable include patients with secondary GBM in clinical therapeutic trials for recurrent disease...
Cushing's disease due to plurihormonal adrenocorticotropic hormone and gonadotropin-producing pituitary adenomaR Egensperger
Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA
Acta Neuropathol 102:398-403. 2001..This represents the second report of a plurihormonal gonadotroph adenoma producing sufficient ACTH to result in pituitary-dependent Cushing's disease...
Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytomaDaniel J Brat
Department of Pathology and Laboratory Medicine, 1364 Clifton Road NE, Atlanta, GA 30322, USA
Brain Pathol 17:319-24. 2007..It is solid in architecture, composed of spindle cells and presumably derived from pituicytes. Pituicytomas are indolent tumours, and are designated WHO grade I...
Analysis of p53 mutation and expression in pleomorphic xanthoastrocytomaC Giannini
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Neurogenetics 3:159-62. 2001..Consequently, our findings suggest that the genetic events that underlie PXA formation differ from those involved in diffuse astrocytoma...
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosisC F Lucchinetti
Department of Neurology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Brain 131:1759-75. 2008..Although increased awareness of this broad spectrum may obviate need for biopsy in many circumstances, an important role for diagnostic brain biopsy may be required in some cases...
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiformeJ S Smith
Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
J Natl Cancer Inst 93:1246-56. 2001....
Mixed conventional and desmoplastic infantile ganglioglioma: an autopsied case with 6-year follow-upT Komori
Department of Pathology and Laboratory MedicineMayo Clinic, Rochester, Minnesota, USA
Mod Pathol 14:720-6. 2001..If so, their derivation may be from multipotential cells of the neural plate...
Fibrous meningioma with tyrosine-rich crystalsM E Couce
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Ultrastruct Pathol 23:341-5. 1999..By morphology, histochemistry, and ultrastructure, the crystals resembled tyrosine-rich crystals occurring in salivary gland tumors. This is the first report of a fibrous meningioma containing tyrosine-rich crystals...
Concurrent solitary fibrous tumor and low-grade fibrillary astrocytoma of the cerebellumJ I Lopez
Department of Laboratory Medicine and Pathology, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, MN, USA
Clin Neuropathol 29:301-6. 2010..We report the clinicopathologic features of a solitary fibrous tumor (SFT) having undergone malignant transformation and being intimately associated with a WHO Grade II astrocytoma...
Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implicationsD X Cai
Department of Pathology, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
J Neuropathol Exp Neurol 60:628-36. 2001..Furthermore, 14q FISH analysis may aid in assessing recurrence risk in histologically benign meningiomas...
Benign metastasizing leiomyomatosis with massive brachial plexus involvement mimicking neurofibromatosis type 1G C W de Ruiter
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA
Clin Neuropathol 25:282-7. 2006..Although a rare condition, BML should be considered in the differential diagnosis of NF and in patients having a history of uterine leiomyoma. The remarkable, selective involvement of the brachial plexus in this case is unexplained...
Galectin-3 Expression in Functioning and Silent ACTH-Producing AdenomasLong Jin
Department of Pathology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Endocr Pathol 16:107-14. 2005..The use of ACTH and Gal-3 immunostaining should help in the diagnosis of silent ACTH adenomas...
Congenital and childhood plexiform (multinodular) cellular schwannoma: a troublesome mimic of malignant peripheral nerve sheath tumorJames M Woodruff
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Am J Surg Pathol 27:1321-9. 2003..These features may lead to a misdiagnosis of malignancy, which could result in harmful overtreatment...
Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma: case reportMark P Piedra
Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55901, USA
Neurosurgery 59:E206; discussion E206. 2006..The differential diagnosis of melanotic lesions of the CPA is discussed as are the prognostic implications of each diagnosis...
Central neurocytoma: management recommendations based on a 35-year experienceJames L Leenstra
Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 67:1145-54. 2007..METHODS AND MATErials: The data from 45 patients with central neurocytomas diagnosed between 1971 and 2003 were retrospectively evaluated. Various combinations of surgery, radiotherapy (RT), and chemotherapy had been used for treatment...
A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?Takashi Komori
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 26:582-91. 2002....
Differential expression of galectin-3 in pituitary tumorsDominik Riss
Department of Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Cancer Res 63:2251-5. 2003..Inhibition of Gal-3 gene expression by RNA interference decreased HP75 cell proliferation and increased apoptosis. These results indicate that Gal-3 has an important role in pituitary cell proliferation and tumor progression...
MGMT immunoexpression in silent subtype 3 pituitary adenomas: possible therapeutic implicationsMichael E Fealey
Mayo Work Study Program, Mayo Clinic, Rochester, MN 55905, USA
Endocr Pathol 21:161-5. 2010..The observed lack of or low-level expression of MGMT by this distinctive, clinically aggressive form of pituitary adenoma suggests potential efficacy of treatment with the alkylating agent temozolomide...
Solitary fibrous tumor of the cerebellopontine angle with salivary gland heterotopia: a unique presentationFausto Rodriguez
Department of Pathology, Mayo Foundation, Rochester, Minnesota 55902, USA
Am J Surg Pathol 28:139-42. 2004..The presence of a myoepithelial cell layer, surrounding some of the acini and highlighted by the smooth muscle actin immunostain, strengthened this interpretation...
Management of malignant pineal germ cell tumors with residual mature teratomaJ A Friedman
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA
Neurosurgery 48:518-22; discussion 522-3. 2001..We reviewed our surgical experience with residual malignant pineal germ cell tumors after neoadjuvant therapy...
Dysembryoplastic neuroepithelial tumor and calcifying pseudoneoplasms of the neuraxis: a collision of two seizure-associated lesionsX Yan
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Clin Neuropathol 30:197-202. 2011..The association of DNET and CPNA has not been previously reported. The literature relevant to these two seizure-associated lesions is reviewed...
The treatable dementia of Sjögren's syndromeR J Caselli
Department of Neurology, Mayo Clinic, Rochester, MN
Ann Neurol 30:98-101. 1991..Treatment with high-dose corticosteroids produced rapid and nearly complete resolution of the dementia...
The results of radiotherapy for brainstem tumorsS E Schild
Mayo Clinic Scottsdale, Department of Radiation Oncology, AZ 85259, USA
J Neurooncol 40:171-7. 1998..This analysis was performed to examine the outcome of adult and pediatric patients with brainstem tumors...
The results of radiotherapy for ependymomas: the Mayo Clinic experienceS E Schild
Mayo Clinic Arizona, Department of Radiation Oncology, Scottsdale 85259, USA
Int J Radiat Oncol Biol Phys 42:953-8. 1998..This analysis was performed to examine the outcome of patients with histologically confirmed ependymomas of the brain or spinal cord who received postoperative radiotherapy...
Anaplasia in pilocytic astrocytoma predicts aggressive behaviorFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Surg Pathol 34:147-60. 2010..In summary, PA with anaplastic features exhibits a spectrum of morphologies and is associated with decreased survival when compared with typical PA...
Rate of spontaneous hemorrhage in histologically proven cases of pilocytic astrocytomaJ Bradley White
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurosurg 108:223-6. 2008..Hemorrhage associated with pilocytic astrocytomas (PAs) is only sporadically reported. The authors report on a series of patients in whom PAs presenting as hemorrhages prompted them to examine the incidence of bleeding in these tumors...
Medial plantar nerve compression by a tibial artery schwannoma. Case reportRobert J Spinner
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurosurg 106:921-3. 2007..Additionally they provide the operative, histological, and imaging findings...
Epineurial compartments and their role in intraneural ganglion cyst propagation: an experimental studyRobert J Spinner
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Anat 20:826-33. 2007..Additional work is needed to be done to correlate these anatomic findings with magnetic resonance imaging and surgical pathology...
The unifying articular (synovial) origin of intraneural ganglia: evolution-revelation-revolutionRobert J Spinner
Departments of Neurologic Surgery, Orthopedics, and Anatomy, Mayo Clinic, Rochester, Minnesota 55905, USA
Neurosurgery 65:A115-24. 2009..This article describes the ongoing process of critically analyzing and challenging previous observations and evidence in an effort to prove a concept and a theory...
Intraneural ganglion cyst: a 200-year-old mystery solvedRobert J Spinner
Mayo Clinic, Department of Neurologic Surgery, Rochester, MN 55905, USA
Clin Anat 21:611-8. 2008..The purpose of this report is to clarify historical misconceptions regarding the pathogenesis of this controversial entity...
Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profilingKatharina H Ruebel
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA
Endocrine 33:62-76. 2008..These findings highlight the diverse gene networks and pathways through which TGFbeta operates in its effects on pituitary tumor cells...
Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case reportRobert J Spinner
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurosurg 107:435-9. 2007..The latter finding supports the suggestion that these were two different clonal neoplasms, and is consistent with a collision tumor pattern...
Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissuesFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Research Center, Mayo Clinic, Rochester, MN 55905, USA
Lab Invest 88:1024-37. 2008..LC-MS/MS represents a novel application for characterization of these deposits and is of diagnostic utility in addition to standard immunohistochemical analyses...
Ependymoma and intraparenchymal calcifying pseudoneoplasm of the neural axis: incidental collision or unique reactive phenomenon?Fausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Acta Neuropathol 115:363-6. 2008..The unique combination of an ependymoma with marked reactive gliosis and a calcifying pseudoneoplasm supports the reactive nature of the latter...
Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapyMichelle L Mauermann
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
J Peripher Nerv Syst 15:216-26. 2010..The primary pathophysiology is unknown but the inflammation and response to treatment suggests that there may be an immune component...
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytomaFausto J Rodriguez
Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA
Brain Pathol 19:623-9. 2009..5 to 5.5 years after first resection. These results suggest that 1p19q loss and t(1;19) occur in a subset of EVN, and may be associated with aggressive histology in these tumors...
Prognosis and treatment of spinal cord astrocytomaKiernan J Minehan
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 73:727-33. 2009..To identify the prognostic factors for spinal cord astrocytoma and determine the effects of surgery and radiotherapy on outcome...
Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic studyFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
Am J Surg Pathol 32:699-709. 2008..Although rare, ependymal neoplasms must be included among the gliomas prone to undergo sarcomatous change and we propose the term "ependymosarcoma" for these tumors...
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic gradeJan C Buckner
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Neurooncol 84:279-86. 2007..Anaplastic oligoastrocytomas (AOA) are relatively uncommon high-grade gliomas. While oligodendroglial elements are thought to be associated with better outcomes, the magnitude of the difference is not clear...
Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expressionKatharina H Ruebel
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA
Endocrine 29:435-44. 2006..These results indicate that the LGALS3, hASH1, ID2, and TLE-4 genes may have important roles in the development of pituitary carcinomas...
Choristoma of the optic nerve: case reportCaterina Giannini
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Neurosurgery 50:1125-8. 2002..Optic nerve choristoma is a rare lesion composed of adipose tissue and smooth muscle involving the optic nerve. Few cases have been reported...
Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypesFausto J Rodriguez
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neuropathol Exp Neurol 67:1194-204. 2008..In summary, we have identified a molecular signature that distinguishes NF1-PA from S-PA and found that ALDH1L1 underexpression is associated with aggressive histology and/or biologic behavior...
Risk of cancer among relatives of patients with gliomaBrian P O'Neill
Department of Neurology, and the Mayo Clinic Cancer Center, Rochester Minnesota 55905, USA
Cancer Epidemiol Biomarkers Prev 11:921-4. 2002..Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene...
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalitiesJan C Buckner
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
J Clin Oncol 21:251-5. 2003....
Granular cell tumor of the sellar and suprasellar region: clinicopathologic study of 11 cases and literature reviewAaron A Cohen-Gadol
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 78:567-73. 2003..To report a series of cases of surgically resected granular cell tumors in an attempt to better characterize their clinical presentation, imaging features, and treatment outcomes with attention to previously published literature...
Spinal meningiomas in patients younger than 50 years of age: a 21-year experienceAaron A Cohen-Gadol
Department of Neurologic Surgery, Mayo Medical School, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
J Neurosurg 98:258-63. 2003..Spinal meningiomas occurring in younger patients may be more aggressive, with a worse prognosis. The authors present their 21-year experience with spinal meningiomas in patients younger than 50 years of age...
Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomasOnder Onguru
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, MN 55905, USA
Mod Pathol 17:772-80. 2004..These results indicate that activated epidermal growth factor receptor is expressed in pituitary adenomas and carcinomas. Higher levels in pituitary carcinomas suggest a role in pituitary tumor progression...
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade gliomaPaul D Brown
Division of Radiation Ocology, Mayo Clinic, Rochester, MN 55905, USA
Int J Radiat Oncol Biol Phys 59:117-25. 2004....
Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patientsRobert D Ecker
Department of Neurologic Surgery, The Mayo Clinic and Foundation, Rochester, Minnesota, USA
J Neurosurg 98:1182-7. 2003..The authors reviewed the Mayo Clinic experience with the treatment of hemangiopericytoma in the primary central nervous system (CNS)...
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis
Mayo Clinic and Mayo Foundation, 200 First St SW, Rochester, MN 55905, USA
J Clin Oncol 23:5294-304. 2005..Temsirolimus (CCI-779) is a small-molecule inhibitor of the mammalian target of rapamycin (mTOR) and represents a rational therapeutic target against glioblastoma multiforme (GBM)...
Immunophenotype of pleomorphic xanthoastrocytomaCaterina Giannini
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Surg Pathol 26:479-85. 2002..We found no evidence that the former is a precursor of the latter...
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology GroupJan C Buckner
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
J Clin Oncol 24:3871-9. 2006....
Peroneal intraneural ganglia: the importance of the articular branch. Clinical seriesRobert J Spinner
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
J Neurosurg 99:319-29. 2003....
